1,065 followers
New publication by a Papworth author: Lifting the fog in intermediate-risk (submassive) PE: full dose, low dose, or no thrombolysis? https://t.co/usTlv2eNc7. #papworthauthors #pulmonaryembolism
New publication by a Papworth author: Lifting the fog in intermediate-risk (submassive) PE: full dose, low dose, or no thrombolysis? https://t.co/usTlv2eNc7. #papworthauthors #pulmonaryembolism
RT @F1000Research: In this faculty review published on @F1000Research, the authors discuss the different therapeutic options available for…
In this faculty review published on @F1000Research, the authors discuss the different therapeutic options available for managing intermediate diseases in patients with acute pulmonary embolism. @BasildonHosp @RoyalPapworth @cuh_nhs https://t.co/PKSrDi7bEh